Restoration of LRIG1 suppresses bladder cancer cell growth by directly targeting EGFR activity

BACKGROUND: Recently, leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1), a negative regulator of EGFR, was discovered is a novel agent for suppressing bladder cancer. The aim of this study was to investigate the impact of LRIG1 on the biological features of aggressive bladder cancer cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Lei, Shi, Runlin, Yang, Tao, Li, Fan, Li, Guohao, Guo, Yonglian, Lang, Bin, Yang, Weimin, Zhuang, Qianyuan, Xu, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880093/
https://www.ncbi.nlm.nih.gov/pubmed/24314030
http://dx.doi.org/10.1186/1756-9966-32-101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880093/
https://www.ncbi.nlm.nih.gov/pubmed/24314030
http://dx.doi.org/10.1186/1756-9966-32-101

Ejemplares similares